Evidence map›Paper›PMID 36944966›Full record

ArticleBMC pulmonary medicine2023

Pulmonary fibrosis model of mice induced by different administration methods of bleomycin.

Aman Gul, Fangyong Yang, Cong Xie, Wenjing Du, Nabijan Mohammadtursun, Bin Wang, Jingjing Le, Jingcheng Dong

Open access · goldFull text read
In one paragraph

Article in BMC pulmonary medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. FAPI TracerPharmaceuticals (Basel, Switzerland) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Rodent Models of Lung Disease: A Road Map for Translational Research.International journal of molecular sciences · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Aman GulDepartment of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
Fangyong YangDepartment of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
Cong XieDepartment of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
Wenjing DuDepartment of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
Nabijan MohammadtursunInstitute of Integrated Traditional Chinese and Western Medicine, Fudan University, Shanghai, 200040, People's Republic of China.
Bin WangDepartment of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
Jingjing Le *Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China. lejingjing2007@126.com.
Jingcheng Dong *Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China. jcdong2004@126.com.
Fudan University · CNHuashan Hospital · CN

Funding

Natural science Foundation of Xinjiang 2022D01C212
6 · The paper itself

Abstract

backgroundIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease of the lung. How to build a typical human mimicking animal model has been a challenge. Thus, to reveal the mechanism and to make it useful for IPF clinical treatment, a different type of mice model and inspection methods are used to evaluate which one is applicable for the study of IPF.

method69 Twelve-weeks-old C57BL/6 mice were divided into 3 type groups (n = 7 for each control group, n = 8 for each BLM-induced pulmonary fibrosis groups), as intraperitoneal injection, intratracheal administration, and intravenous administration of bleomycin (BLM) to initiate lung fibrosis. Changes of the lung function measured through mice Pulmonary function test (PFT). Morphological changes in mice were observed by PET/CT, Masson and Picro-Sirius staining, Transmission electron microscopy (TEM). Biochemical changes were tested by Enzyme-linked immunosorbent assay (Elisa).

resultsPET/CT of BLM-receiving mice showed an increase in fibrotic consolidations and an increase in non-aerated lung area in BLM-treated mice compared with that in controls. TGF-b1, TNF-a, IL-6, GM-CSF in BALF and serum. PAI-1, HYP in the lung tissue of mice were significantly different in each BLM groups than those in the controls. The results of Masson staining in mice indicate that the lung tissues of all BLM received groups, the intratracheal groups, the intravenous groups, and the intraperitoneal groups have a higher degree of pulmonary septal thickening and collagen fiber consolidation compare to saline control. Picro-Sirius staining results are consistent with the results of Masson staining. Compared with the saline control group, the ratio of Col 1/Col 3 was significantly increased in each BLM group. TEM results found that in BLM group, type I alveolar epithelial cells were degenerated. Exfoliated endothelial cells were swelling, and type II alveolar epithelial cells were proliferated, the shape of the nucleus was irregular, and some tooth-like protrusions were seen.

conclusionsWith three different methods of animal model construction, high dose of each show more compliable, and BLM can successfully induce animal models of pulmonary fibrosis, however, certain differences in the fibrosis formation sites of them three, and tail vein injection of BLM induced PF model is closer to the idiopathic pulmonary interstitial fibrosis.

Indexed as

BleomycinIdiopathic Pulmonary FibrosisAnimalsBronchoalveolar Lavage FluidDisease Models, AnimalEndothelial CellsHumansLungMiceMice, Inbred C57BLPositron Emission Tomography Computed TomographyBleomycin18F-FDG3D ROI reconstructionBleomycinIPF mice model

Identifiers

PMID36944966
PMCPMC10029181
OpenAlexW4328119672

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read46
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.